Why Biotech Needs a Different FSP Model

Many Functional Service Provider (FSP) models were designed with large pharmaceutical organizations in mind. But biotech companies face a different set of challenges: lean teams, evolving pipelines, shifting priorities, and limited internal resources. As development programs advance, sponsors often need greater flexibility than conventional outsourcing models can provide. This eBook explores how a biotech-tailored FSP model can help sponsors access specialized expertise, scale resources as needs change, and maintain momentum without adding unnecessary operational complexity.

Share the Post:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to our use of all cookies, however, you may visit “Cookies Setting” to provide a controlled consent.

Privacy Policy